TherapeuticsMD, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
TherapeuticsMD, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q2 2024.
  • TherapeuticsMD, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 12, 2024 was 11.5M shares, a 9.05% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 11.5M +957K +9.05% Aug 12, 2024 10-Q 2024-08-12
Q1 2024 11.5M +1.58M +15.9% Mar 27, 2024 10-K 2024-03-29
Q3 2023 10.6M +1.11M +11.7% Nov 14, 2023 10-Q 2023-11-14
Q2 2023 10.6M +1.15M +12.2% Aug 9, 2023 10-Q 2023-08-14
Q1 2023 9.95M -423M -97.7% Apr 5, 2023 10-K 2023-04-07
Q3 2022 9.47M -415M -97.8% Nov 11, 2022 10-Q 2022-11-14
Q2 2022 9.42M -414M -97.8% Aug 8, 2022 10-Q 2022-08-15
Q1 2022 433M +45.6M +11.8% Mar 17, 2022 10-K 2022-03-23
Q3 2021 425M +152M +55.8% Nov 11, 2021 10-Q 2021-11-12
Q2 2021 424M +152M +55.6% Aug 4, 2021 10-Q 2021-08-04
Q1 2021 388M +116M +42.7% Mar 1, 2021 10-K 2021-03-04
Q3 2020 273M +1.64M +0.6% Nov 2, 2020 10-Q 2020-11-09
Q2 2020 272M -241B Aug 3, 2020 10-Q 2020-08-07
Q1 2020 272M +30.5M +12.6% Apr 20, 2020 10-K/A 2020-04-29
Q3 2019 271M +33.3M +14% Nov 4, 2019 10-Q 2019-11-08
Q2 2019 241B* +241B Aug 2, 2019 10-Q 2019-08-09
Q1 2019 241M +24.6M +11.4% May 1, 2019 10-Q 2019-05-08
Q3 2018 238M +21.5M +9.91% Nov 1, 2018 10-Q 2018-11-08
Q2 2018 217M +12.8M +6.28% Jul 23, 2018 10-Q 2018-07-30
Q1 2018 217M +12.7M +6.21% Apr 30, 2018 10-Q 2018-05-07
Q3 2017 216M +19.8M +10.1% Oct 30, 2017 10-Q 2017-11-07
Q2 2017 204M +7.53M +3.84% Jul 31, 2017 10-Q 2017-08-03
Q1 2017 204M +7.66M +3.91% Apr 27, 2017 10-Q 2017-05-03
Q3 2016 197M +18.7M +10.5% Oct 31, 2016 10-Q 2016-11-04
Q2 2016 196M +19M +10.7% Aug 1, 2016 10-Q 2016-08-05
Q1 2016 196M +24.5M +14.3% May 2, 2016 10-Q 2016-05-05
Q3 2015 178M +21.8M +14% Nov 2, 2015 10-Q 2015-11-05
Q2 2015 178M +21.7M +13.9% Aug 3, 2015 10-Q 2015-08-07
Q1 2015 172M +26.7M +18.4% Mar 6, 2015 10-K 2015-03-12
Q3 2014 156M +11.1M +7.63% Nov 4, 2014 10-Q 2014-11-07
Q2 2014 156M +24.6M +18.7% Aug 4, 2014 10-Q 2014-08-07
Q1 2014 145M +45.2M +45.3% Mar 3, 2014 10-K 2014-03-05
Q3 2013 145M +45.2M +45.3% Nov 4, 2013 10-Q 2013-11-05
Q2 2013 131M +35.5M +37% Aug 7, 2013 10-Q 2013-08-07
Q1 2013 99.8M +15.2M +17.9% Feb 28, 2013 10-K 2013-03-12
Q3 2012 99.8M +18.6M +22.9% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 95.8M Jun 30, 2012 10-Q 2012-08-09
Q1 2012 84.6M Mar 23, 2012 10-K 2012-03-27
Q4 2011 83M Dec 31, 2011 10-Q 2012-11-13
Q3 2011 81.2M Nov 7, 2011 10-Q 2011-11-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.